RevivBio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 12

RevivBio General Information

Description

Operator of a bioengineering and data-driven molecular design platform intended to protect plants and animals from resistant pests and pathogens. The company's platform integrates protein engineering, microfluidics, and AI-driven analytics to generate high-throughput experimental data, enabling biotechnology companies to accelerate the development of functional biologics for crop, human, and animal health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 750 Main Street
  • Cambridge, MA 02139
  • United States
+1 (607)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 750 Main Street
  • Cambridge, MA 02139
  • United States
+1 (607)

RevivBio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RevivBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 01-Feb-2025 Completed Generating Revenue
8. Grant 15-Sep-2024 Completed Generating Revenue
7. Accelerator/Incubator 02-Apr-2024 Completed Generating Revenue
6. Seed Round 07-Feb-2024 Completed Generating Revenue
5. Seed Round 01-Jul-2023 Completed Generating Revenue
4. Accelerator/Incubator 01-Apr-2023 Completed Generating Revenue
3. Accelerator/Incubator 20-Mar-2023 Completed Generating Revenue
2. Accelerator/Incubator 14-Oct-2022 $100K $237K Completed Generating Revenue
1. Angel (individual) 03-Oct-2022 $137K $137K Completed Generating Revenue
To view RevivBio’s complete valuation and funding history, request access »

RevivBio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-3
Seed-2
Seed-1 249,374 $0.000010 6% $12.03 $12.03 1x $12.03 18.17%
To view RevivBio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RevivBio Patents

RevivBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024163931-A1 Enzymatic degradation of poly and perfluorinated compounds Inactive 03-Feb-2023

RevivBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RevivBio Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
US National Science Foundation Accelerator/Incubator
Alumni Ventures Venture Capital Minority
BioGenerator Ventures Venture Capital Minority
Seventure Venture Capital Minority
SNO Management Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

RevivBio FAQs

  • When was RevivBio founded?

    RevivBio was founded in 2021.

  • Where is RevivBio headquartered?

    RevivBio is headquartered in Cambridge, MA.

  • What is the size of RevivBio?

    RevivBio has 9 total employees.

  • What industry is RevivBio in?

    RevivBio’s primary industry is Discovery Tools (Healthcare).

  • Is RevivBio a private or public company?

    RevivBio is a Private company.

  • What is RevivBio’s current revenue?

    The current revenue for RevivBio is .

  • How much funding has RevivBio raised over time?

    RevivBio has raised $3.29M.

  • Who are RevivBio’s investors?

    US National Science Foundation, Alumni Ventures, BioGenerator Ventures, Seventure, and SNO Management are 5 of 12 investors who have invested in RevivBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process